Differential diagnosis of pancreatic tumors by molecular analysis of clinical specimens

Pancreatology

Volumn 8, Issue 6, 2008, Pages 551-557

  Buchholz, Malte ^a   Kestler, Hans ^b,c   Gress, Thomas M ^a,d  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Differential diagnosis; Molecular markers; Multiplex assays; Pancreatic cancer

Indexed keywords

CYCLIN D2; PROTEIN P16; PROTEIN S 100; SOMATOMEDIN B;

ASPIRATION BIOPSY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DNA MICROARRAY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE ANGIOGRAPHY; METHYLATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CYST; PANCREAS JUICE; PANCREAS TUMOR; POINT MUTATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; ULTRASOUND;

EID: 52349105475     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000159213     Document Type: Article

References (88)

1. Carriaga MT, Henson DE: Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995;75:171-190.
2. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
3. Abraham SC, Wilentz RE, Yeo CJ, et al: Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am J Surg Pathol 2003;27:110-120.
4. Weber SM, Cubukcu-Dimopulo O, Palesty JA, et al: Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003;7:129-137.
5. Ariyama J, Suyama M, Satoh K, et al: Imaging of small pancreatic ductal adenocarcinoma. Pancreas 1998;16:396-401.
6. Ghaneh P, Costello E, Neoptolemos JP: Biology and management of pancreatic cancer. Gut 2007;56:1134-1152.
7. Hearle N, Schumacher V, Menko FH, et al: Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 2006;12:3209-3215.
8. Boardman LA, Thibodeau SN, Schaid DJ, et al: Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 1998;128:896-899.
9. Lowenfels AB, Maisonneuve P: Risk factors for pancreatic cancer. J Cell Biochem 2005;95:649-656.
10. Howes N, Lerch MM, Greenhalf W, et al: Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004;2:252-261.
11. Lynch HT, Fusaro RM, Lynch JF, et al: Pancreatic cancer and the FAMMM syndrome. Fam Cancer 2008;7:103-112.
12. Lynch HT, Brand RE, Hogg D, et al: Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinomaprone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 2002;94:84-96.
13. Klein AP, Hruban RH, Brune KA, et al: Familial pancreatic cancer. Cancer J 2001;7:266-273.
14. Klein AP, Brune KA, Petersen GM, et al: Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004;64:2634-2638.
15. Jhala NC, Jhala DN, Chhieng DC, et al: Endoscopic ultrasound-guided fine-needle aspiration. A cytopathologist's perspective. Am J Clin Pathol 2003;120:351-367.
16. Chhieng DC, Jhala D, Jhala N, et al: Endoscopic ultrasound-guided fine-needle aspiration biopsy: a study of 103 cases. 2002;96:232-239.
17. Brandwein SL, Farrell JJ, Centeno BA, et al: Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointest Endosc 2001;53:722-727.
18. Eloubeidi MA, Chen VK, Eltoum IA, et al: Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol 2003;98:2663-2668.
19. Klapman JB, Logrono R, Dye CE, et al: Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2003;98:1289-1294.
20. Shin HJ, Lahoti S, Sneige N: Endoscopic ultrasound-guided fine-needle aspiration in 179 cases: the M.D. Anderson Cancer Center experience. Cancer 2002;96:174-180.
21. Selvaggi SM: Biliary brushing cytology. Cytopathology 2004;15:74-79.
22. Govil H, Reddy V, Kluskens L, et al: Brush cytology of the biliary tract: retrospective study of 278 cases with histopathologic correlation. Diagn Cytopathol 2002;26:273-277.
23. Farrell RJ, Jain AK, Brandwein SL, et al: The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures. Gastrointest Endosc 2001;54:587-594.
24. Mansfield JC, Griffin SM, Wadehra V, et al: A prospective evaluation of cytology from biliary strictures. Gut 1997;40:671-677.
25. Li D, Xie K, Wolff R, et al: Pancreatic cancer. Lancet 2004;363:1049-1057.
26. Harada T, Chelala C, Bhakta V, et al: Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays. Oncogene 2008;27:1951-1960.
27. Harada T, Baril P, Gangeswaran R, et al: Identification of genetic alterations in pancreatic cancer by the combined use of tissue microdissection and array-based comparative genomic hybridisation. Br J Cancer 2007;96:373-382.
28. Nowak NJ, Gaile D, Conroy JM, et al: Genome-wide aberrations in pancreatic adenocarcinoma. Cancer Genet Cytogenet 2005;161:36-50.
29. Holzmann K, Kohlhammer H, Schwaenen C, et al: Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res 2004;64:4428-4433.
30. Gress TM, Muller-Pillasch F, Geng M, et al: A pancreatic cancer-specific expression profile. Oncogene 1996;13:1819-1830.
31. Han H, Bearss DJ, Browne LW, et al: Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 2002;62:2890-2896.
32. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, et al: Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001;20:7437-7446.
33. Crnogorac-Jurcevic T, Efthimiou E, Nielsen T, et al: Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 2002;21:4587-4594.
34. Iacobuzio-Donahue CA, Maitra A, Olsen M, et al: Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003;162:1151-1162.
35. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, et al: Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 2002;160:1239-1249.
36. Buchholz M, Braun M, Heidenblut A, et al: Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 2005;24:6626-6636.
37. Grutzmann R, Foerder M, Alldinger I, et al: Gene expression profiles of microdissected pancreatic ductal adenocarcinoma. Virchows Arch 2003;443:508-517.
38. Grutzmann R, Pilarsky C, Ammerpohl O, et al: Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 2004;6:611-622.
39. Jin G, Hu XG, Ying K, et al: Discovery and analysis of pancreatic adenocarcinoma genes using cDNA microarrays. World J Gastroenterol 2005;11:6543-6548.
40. Logsdon CD, Simeone DM, Binkley C, et al: Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003;63:2649-2657.
41. Nakamura T, Furukawa Y, Nakagawa H, et al: Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 2004;23:2385-2400.
42. Prasad NB, Biankin AV, Fukushima N, et al: Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 2005;65:1619-1626.
43. Friess H, Ding J, Kleeff J, et al: Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci 2003;60:1180-1199.
44. Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, et al: Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 2005;129:1454-1463.
45. Chen R, Pan S, Brentnall TA, et al: Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics 2005;4:523-533.
46. Chen R, Yi EC, Donohoe S, et al: Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology 2005;129:1187-1197.
47. Shekouh AR, Thompson CC, Prime W, et al: Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 2003;3:1988-2001.
48. Shen J, Person MD, Zhu J, et al: Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 2004;64:9018-9026.
49. Sato N, Fukushima N, Hruban RH, et al: CpG island methylation profile of pancreatic intraepithelial neoplasia. Mod Pathol 2008;21:238-244.
50. Sato N, Goggins M: Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg 2006;13:280-285.
51. Sato N, Matsubayashi H, Abe T, et al: Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. Clin Cancer Res 2005;11:4681-4688.
52. Ueki T, Toyota M, Skinner H, et al: Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer Res 2001;61:8540-8546.
53. Pugliese V, Pujic N, Saccomanno S, et al: Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and K-ras-2 codon 12 molecular analysis in 47 cases. Gastrointest Endosc 2001;54:595-599.
54. Van Laethem JL, Bourgeois V, Parma J, et al: Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases. Gastrointest Endosc 1998;47:479-485.
55. Luttges J, Schlehe B, Menke MA, et al: The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer 1999;85:1703-1710.
56. Yan L, McFaul C, Howes N, et al: Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups. Gastroenterology 2005;128:2124-2130.
57. Salek C, Benesova L, Zavoral M, et al: Evaluation of clinical relevance of examining Kras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer. World J Gastroenterol 2007;13:3714-3720.
58. Khalid A, Pal R, Sasatomi E, et al: Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples. Gut 2004;53:1860-1865.
59. Khalid A, McGrath KM, Zahid M, et al: The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol 2005;3:967-973.
60. Khalid A, Nodit L, Zahid M, et al: Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses. Am J Gastroenterol 2006;101:2493-2500.
61. Nielsen J, Christiansen J, Lykke-Andersen J, et al: A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999;19:1262-1270.
62. Mueller-Pillasch F, Lacher U, Wallrapp C, et al: Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 1997;14:2729-2733.
63. Mueller-Pillasch F, Pohl B, Wilda M, et al: Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev 1999;88:95-99.
64. Mueller F, Bommer M, Lacher U, et al: KOC is a novel molecular indicator of malignancy. Br J Cancer 2003;88:699-701.
65. Yantiss RK, Woda BA, Fanger GR, et al: KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol 2005;29:188-195.
66. Zhao H, Mandich D, Cartun RW, et al: Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas. Diagn Cytopathol 2007;35:700-704.
67. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, et al: Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 2003;201:63-74.
68. Logsdon CD, Simeone DM, Binkley C, et al: Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003;63:2649-2657.
69. Sato N, Fukushima N, Matsubayashi H, et al: Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene 2004;23:1531-1538.
70. Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, et al: Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol 2005;166:81-92.
71. Deng H, Shi J, Wilkerson M, et al: Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens. Am J Clin Pathol 2008;129:81-88.
72. Ohuchida K, Mizumoto K, Egami T, et al: S100P is an early developmental marker of pancreatic carcinogenesis. Clin Cancer Res 2006;12:5411-5416.
73. Balague C, Audie JP, Porchet N, et al: In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. Gastroenterology 1995;109:953-964.
74. Balague C, Gambus G, Carrato C, et al: Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. Gastroenterology 1994;106:1054-1061.
75. Andrianifahanana M, Moniaux N, Schmied BM, et al: Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res 2001;7:4033-4040.
76. Kim GE, Bae HI, Park HU, et al: Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology 2002;123:1052-1060.
77. Ohuchida K, Mizumoto K, Yamada D, et al: Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer. Int J Cancer 2006;118:405-411.
78. Chhieng DC, Benson E, Eltoum I, et al: MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Cancer 2003;99:365-371.
79. Wang Y, Gao J, Li Z, et al: Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas. Int J Cancer 2007;121:2716-2722.
80. Giorgadze TA, Peterman H, Baloch ZW, et al: Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation. Cancer 2006;108:186-197.
81. Jhala N, Jhala D, Vickers SM, et al: Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates. Am J Clin Pathol 2006;126:572-579.
82. Bhardwaj A, Marsh WL Jr, Nash JW, et al: Double immunohistochemical staining with MUC4/p53 is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray-based study. Arch Pathol Lab Med 2007;131:556-562.
83. Feinberg AP, Tycko B: The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-153.
84. Matsubayashi H, Canto M, Sato N, et al: DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 2006;66:1208-1217.
85. Park JK, Ryu JK, Lee KH, et al: Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer. Pancreas 2007;35:e9-e15.
86. Buchholz M, Kestler HA, Bauer A, et al: Specialized DNA arrays for the differentiation of pancreatic tumors. Clin Cancer Res 2005;11:8048-8054.
87. Tibshirani R, Hastie T, Narasimhan B, et al: Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002;99:6567-6572.
88. Kestler HA, Müssel C: An empirical comparison of feature reduction methods in the context of microarray data classification;in Schwenker F, Marinai S (eds): Artificial Neural Networks in Pattern Recognition (ANNPR 06). Heidelberg, Springer, 2006, vol LNAI 4087, pp 260-273.